Operator of behavioral health and addiction treatment facilities, including inpatient psychiatric hospitals across the US.
Operator of behavioral health and addiction treatment facilities, including inpatient psychiatric hospitals across the US.
Is paid per patient day by government programs and private insurers, so occupancy and the mix of payers drive income. It grew through acquisitions and joint ventures with health systems, and sold its UK business in 2021 to focus on the US.
Moat: narrow (scale, regulatory licence). Large network of licensed psychiatric facilities amid limited supply of behavioral-health beds nationally.
Headquarters: Franklin, Tennessee · Founded: 2005 · Employees: 25,000
Size Acadia Healthcare (ACHC) is a United States Health Care company (Medical/Nursing Services) with a market value of $3.49B, the 1433rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $37.59 on 18 Nov 2026.
Performance Over six months the shares gained 56.2%, against +21.3% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 20 in its peer set.
Growth Revenue grew 4.5% over the last twelve months (peer median +11.7%); the operating margin is 9.8% (peer median 8.2%).
Valuation It trades at 18.6× forward earnings against a peer median of 39.0× (6th cheapest of 18).
Capital Return on invested capital runs 1.6 points below its cost of capital (7.1% WACC).
Credit Acadia Healthcare has 1 bond outstanding ($475M), rated B+ by the agencies and trading like BBB- at a weighted spread of 128 bp.
Short interest Short interest is 20.4% of the free float (30 Oct 2026).
Next results Next results expected around 1 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $3.41B | $3.31B | $3.15B | $2.93B | $2.61B |
| Revenue growth | — | +5% | +8% | +12% | — |
| Gross profit | $549M | $583M | $712M | $683M | $604M |
| EBITDA | $535M | $577M | $672M | $639M | $564M |
| Net income | -$1.13B | -$1.10B | $256M | -$21.7M | $273M |
| Free cash flow | -$23.9M | -$440M | -$561M | $38.2M | $84.4M |
| Capital expenditure | $259M | $572M | $690M | $424M | $296M |
| Total debt | $2.50B | $2.65B | $2.10B | $1.51B | $1.54B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Acadia Healthcare ACHC | $3.49B | +56% | +4% | 10% | 18.6× | n/a |
| Universal Health Services UHS | $10.7B | +13% | +8% | 11% | 8.3× | -1.8% |
| Lifestance Health LFST | $5.24B | +79% | +23% | 6% | 51.8× | 33.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ACHC | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +19.6% | +1.8% | 3rd highest of 21 |
| 6-month return | +56.2% | +21.3% | 5th highest of 20 |
| Distance from 52-week high | -5.3% | -12.9% | 4th highest of 21 |
| Revenue growth (TTM) | +4.5% | +11.7% | 8th lowest of 21 |
| Operating margin | 9.8% | 8.2% | 9th highest of 21 |
| Forward P/E | 18.6× | 39.0× | 6th cheapest of 18 |
| ROIC minus cost of capital | -1.6 pp | +0.0 pp | 10th lowest of 21 |
| EV / EBITDA | 11.3× | 15.4× | 4th cheapest of 16 |
| Net debt / EBITDA | 4.4× | 2.6× | 5th most indebted of 19 |
| Bond spread | 128 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Acadia Healthcare ACHC | United States | $3.49B | +56% | +4% | 10% | 18.6× | n/a | n/a |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.53B | +15% | +17% | 24% | 50.5× | 32.3% | +11.8% |
| Medicover MCOV-B.ST | Sweden | $3.87B | +21% | +3% | 7% | 36.1× | 19.6% | +20.2% |
| Hims & Hers Health HIMS | United States | $4.00B | -26% | +30% | -1% | n/a | n/a | n/a |
| BillionToOne BLLN | United States | $4.37B | +7% | +72% | 10% | 115.3× | 22.8% | +71.9% |
| Fameglow 3774.HK | Hong Kong | $4.54B | n/a | +36% | 11% | n/a | 57.4% | +48.4% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.60B | -27% | -4% | 9% | 49.6× | 4.2% | +5.7% |
| Option Care Health OPCH | United States | $4.75B | +43% | +4% | 6% | 15.7× | 2.0% | +13.2% |
| Pediatrix Medical MD | United States | $2.41B | +37% | +2% | 12% | 12.4× | -4.4% | +2.0% |
| Aveanna Healthcare AVAH | United States | $2.37B | +41% | +17% | 12% | 12.2× | 7.7% | +10.2% |
| Lifestance Health LFST | United States | $5.24B | +79% | +23% | 6% | 51.8× | 33.4% | +30.4% |
| Concentra Group Holdings Parent CON | United States | $5.31B | +65% | +12% | 17% | 22.3× | 3.6% | +7.9% |
| Addus HomeCare ADUS | United States | $2.25B | +29% | +12% | 11% | 16.2× | 4.0% | +13.2% |
| RadNet RDNT | United States | $5.66B | +32% | +21% | 5% | 93.2× | 38.8% | +13.7% |
| AddLife ALIF-B.ST | Sweden | $2.13B | +15% | +2% | 8% | 39.0× | 21.1% | +14.6% |
| Azenta AZTA | United States | $2.03B | +162% | +5% | -2% | 83.2× | 38.0% | +3.9% |
| NeoGenomics NEO | United States | $1.98B | +72% | +11% | -6% | 53.5× | n/a | n/a |
| Dr. Agarwal's Health Care AGARWALEYE.NS | India | $1.86B | +20% | +26% | 15% | 77.1× | 43.0% | +26.9% |
| Guangzhou Kingmed Diagnostics 603882.SS | China | $1.86B | +5% | -3% | 7% | 29.9× | 5.4% | -6.1% |
| Emeis EMEIS.PA | France | $1.78B | -33% | +4% | 3% | n/a | 21.2% | +8.5% |
| Sonic Healthcare SHL.AX | Australia | $6.87B | +6% | +14% | 9% | 17.4× | 9.1% | +3.5% |
Acadia Healthcare has 1 bond outstanding with $475M face value. The agencies rate it B+; its bonds trade like BBB-. Weighted yield 5.87%, a spread of 128 bp over government bonds.